The company was founded in 2016 by two cardiologists from the University of Pittsburgh, Dr. Matthew Jones and Dr. G. Stuart Mendenhall, who saw an opportunity to improve treatment of patients with cardiac arrhythmias. Drs. Jones and Mendenhall filed patents on devices and algorithms to support this opportunity.
The University decided to commercialize this technology through their Pitt Innovation Institute, and they formed a Virginia-based LLC called Grektek. The original management team purchased the assets of a mobile health software firm, and its president, Greg Eoyang, became our Chief Technology Officer. John McCauley joined in early 2017 as CEO, and the company adopted ‘everbeat’ as its brand name.
Everbeat has been developing wearable cardiac devices for 5 years, as well as complementary applications for patients to view and manage their health data, and a physician portal where doctors can monitor their patients.
Working with a Brooklyn-based product development partner, everbeat completed development of the prototype everbeat Ring in late 2021. Recognizing the importance of more focus on the venture, Dr. Matthew Jones assumed the CEO role in January 2022. For continuity, John remains engaged as an Advisor to the firm.
Our focus in 2022 is to bring the everbeat Ring to market, along with an everbeat patch that can be used to provide important supplemental ECG data. We are currently building out our management team and Board of Directors to help lead the company into its exciting future.
The everbeat platform mission is to help dramatically improve cardiac care. We want to help our customers predict possible cardiac issues, prevent serious illness, and empower them with information crucial to managing their heart health. Predict. Prevent. Empower.
We have designed the everbeat Ring to be elegant and simple, allowing patients to take better care of themselves through regular monitoring of their heart health. We believe that patients will enjoy the everbeat solution, which means they will use it consistently for a long time – and sustained use of a cardiac monitoring platform is essential to getting healthy.
The electrocardiogram (ECG) is an incredibly powerful diagnostic tool, and the everbeat Ring allows patients to record many different ECG leads. This information, when analyzed through AI-based algorithms, can provide critical feedback to the patient and their physician which will help them achieve our goal of identifying disease earlier and preventing serious events like a stroke or heart attack.
In summary, our mission at Grektek is to build enabling technology — starting with the everbeat Ring-based platform — that makes it simple for heart patients and their support team to better manage their heart health. Pure connected health, on your finger.
Howard, Columbia, UPMC
Icahn School of Med, Mt. Sinai
Interventional cardiologist in private practice in Brooklyn
CMO Harvard, MIT, UPMC Clinical cardiac electro-physiologist, Scripps Hospital Research interests in signal processing and analysis
Our team is made up of experts in cardiology and health tems, strategically positioning our business for success.